Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07245719 · ClinicalTrials.gov registry record
Stryker Universal Midface and Upper-Face Fixation System: A Retrospective Post Market Follow Up
A clinical trial of Orbital Fractures and Zygomatic Fractures, sponsored by Stryker Craniomaxillofacial.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT07245719: Recruiting study of Orbital Fractures and Zygomatic Fractures, sponsored by Stryker Craniomaxillofacial.
NCT07245719 is a study of Orbital Fractures and Zygomatic Fractures that is actively recruiting participants, run by Stryker Craniomaxillofacial. The registered enrollment target is 120 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07245719, a study of Orbital Fractures and Zygomatic Fractures, is actively recruiting participants, sponsored by Stryker Craniomaxillofacial.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
A retrospective post-market clinical follow-up to confirm the performance and safety of the Upper-Face and Mid-Face modules of the Stryker Universal CMF System in a clinical setting. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.
Primary Outcome
Assessed by reviewing adverse events in patient medical charts at time point after surgery. Used to document whether an unplanned revision surgery was required or not for patients.
Conditions Studied
Interventions
- DEVICE Upper-Face and/or Mid-Face modules (1.2 / 1.7 modules) of the Stryker Universal CMF System
Study Locations (1)
New York
- Weill Cornell Medicine Oral and Maxillofacial Surgery 525 East 68th Street, F-2132 - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-03-28 |
| Est. Completion | 2026-02 |
What NCT07245719 shows while recruiting
NCT07245719 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 4 conditions, with Orbital Fractures appearing as the primary indexed condition, and to 1 intervention - of which Upper-Face and/or Mid-Face modules (1.2 / 1.7 modules) of the Stryker Universal CMF System is the first listed.
NCT07245719 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07245719 about?
NCT07245719 is a clinical study titled "Stryker Universal Midface and Upper-Face Fixation System: A Retrospective Post Market Follow Up". A retrospective post-market clinical follow-up to confirm the performance and safety of the Upper-Face and Mid-Face modules of the Stryker Universal CMF System in a clinical setting. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on ...
What is the current status of trial NCT07245719?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-03-28. Estimated completion is 2026-02.
What conditions does trial NCT07245719 study?
This clinical trial studies the following conditions: Orbital Fractures, Zygomatic Fractures, Maxilla Fractures, Facial Fractures.
What interventions are being tested in trial NCT07245719?
The interventions under investigation include: Upper-Face and/or Mid-Face modules (1.2 / 1.7 modules) of the Stryker Universal CMF System (DEVICE).
Who is sponsoring clinical trial NCT07245719?
This trial is sponsored by Stryker Craniomaxillofacial, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07245719 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Orbital Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI